Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing
Briefings in Bioinformatics · 2026
DOI: 10.1093/bib/bbag203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, 2026. Verfasst von Aleksandra Zielińska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants - National Research Institute, Kolejowa 2, 62-064 Ple…. Hauptthemen laut MEDLINE: Drug Repositioning, Artificial Intelligence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCD research scheme fund 2024-2029.
Abstract (Originalsprache)
Artificial Intelligence (AI) plays an increasingly significant role in drug research and development, particularly in drug repurposing, which involves identifying new therapeutic indications for existing pharmacological compounds. From classical algorithms-based tools e.g. DrugRep and DrugRepo, to more recent innovations (e.g. RosettaVS, RepurposeDrugs), this paper reviews the latest AI methods (e.g. AlphaFold3, mediKanren, AdaDR, TxGNN) and their design applications in drug repurposing, particularly in machine learning, deep learning, and biological network analysis. It discusses strategies using predictive models, natural language processing, and big data analysis to accelerate the identification of promising candidates for clinical repurposing. Data availability, model interpretability, and results validation challenges are also highlighted. This review suggests that AI represents a groundbreaking tool in drug repurposing, ranging from protein structure prediction to knowledge graph reasoning, which can significantly reduce the time and costs of developing new therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants - National Research Institute, Kolejowa 2, 62-064 Plewiska, Poland.
- Faculty of Medicine, Poznan University of Medical Sciences, Collegium Maius ul. Fredry 10, 61-701 Poznan, Poland.
- Oklahoma Medical Research Foundation, 825 NE 13th St.Oklahoma City, 73104 Oklahoma, United States.
- Department of Medical Biology and Genetics, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.
- Department of Pharmacognosy and Biomaterials, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
- UCD School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin 4, D04 V1W8 Dublin, Ireland.
ORCID-Profile: Eliana B Souto
Förderung
- UCD research scheme fund 2024-2029
Zitieren
APA
Zielińska, A., Fornalik, M., Szczepaniak, M., Gimla, M., Lemańska, A., Cielecka-Piontek, J., & Souto, E. B. (2026). Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbag203
Vancouver
Zielińska A, Fornalik M, Szczepaniak M, Gimla M, Lemańska A, Cielecka-Piontek J, et al. Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing. Briefings in Bioinformatics. 2026. doi:10.1093/bib/bbag203
BibTeX
@article{Zieliska2026,
author = {Zielińska, Aleksandra and Fornalik, Michał and Szczepaniak, Mateusz and Gimla, Mariola and Lemańska, Anna and Cielecka-Piontek, Judyta and Souto, Eliana B},
title = {Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing},
journal = {Briefings in Bioinformatics},
year = {2026},
doi = {10.1093/bib/bbag203}
}
EUVIMED